Fusion Antibodies
United KingdomEntry
2013
Hold
4yr
Exit
2017
Who owns Fusion Antibodies?
Fusion Antibodies is a British Biotech company, formerly owned by Clarendon Fund Managers, exited in 2017 (exit via IPO). No current private equity owner is on file.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
Exit Type
IPO
Exit Year
2017
More from Co-Fund NI
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Fusion Antibodies?
Fusion Antibodies was formerly owned by Clarendon Fund Managers, exited in 2017. No current private equity owner is on file.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue